EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Implications of ADIPOQ, GAS5, GATA4, and YAP1 Methylation in Triple-Negative Breast Cancer Prognosis

Mateusz Wichtowski, Agnieszka Kołacińska-Wow, Katarzyna Skrzypek iD, Ewa Jabłońska iD, Katarzyna Płoszka iD, Damian Kołat iD, Sylwia Paszek iD, Izabela Zawlik iD, Elżbieta Płuciennik iD, Natalia Potocka iD, Wojciech Fendler, Paweł Kurzawa und 4 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mateusz Wichtowski und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Institute of Oncology, Poznan University of Medical Sciences Szamarzewskiego 84, 60-569 Poznan, Poland. Hauptthemen laut MEDLINE: DNA Methylation, Triple Negative Breast Neoplasms, Adiponectin, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to investigate the prognostic and predictive properties of four specific genes in triple-negative breast cancer (TNBC). We focused on ADIPOQ, GAS5, GATA4, and YAP1, which are known for their roles in key molecular pathways related to tumorigenesis, such as adipokine signaling, lncRNA regulation, transcriptional control, and Hippo signaling, but have not been sufficiently explored in the context of epigenetic regulation in breast cancer. Using the methylospecific PCR (MSP) method, we analyzed the methylation of the four genes in the tumor tissues collected from 57 TNBC patients. We evaluated their association with response to neoadjuvant treatment and clinicopathological characteristics. Additionally, we performed a bioinformatic analysis of methylation and expression data from The Cancer Genome Atlas (TCGA) TNBC cohort to explore their relationships with overall survival (OS), disease-specific survival (DSS), disease-free interval (DFI), progression-free interval (PFI), and relapse-free survival (RFS). No significant associations were observed between methylation patterns and clinicopathological characteristics in the patients. However, in silico analysis of the TNBC cohort identified ADIPOQ methylation as having the most significant associations, correlating with all five survival endpoints, including OS, DSS, DFI, PFI, and RFS. GAS5 methylation was significantly associated with OS, DSS, and RFS, and GATA4 methylation showed significant associations with PFI, whereas YAP1 methylation was significantly associated with OS and RFS. In addition, GAS5 expression was linked to DSS, DFI and RFS. This study highlights the potential prognostic significance of the epigenetic regulation of ADIPOQ in TNBC. The in silico findings shed light on the molecular pathways associated with TNBC progression and warrant further investigation to validate their role in clinical outcomes and underlying biological mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationTriple Negative Breast NeoplasmsAdiponectinAdaptor Proteins, Signal TransducingGATA4 Transcription FactorTranscription FactorsHumansFemaleYAP-Signaling ProteinsPrognosisMiddle AgedGene Expression Regulation, NeoplasticEpigenesis, GeneticAdultAgedBiomarkers, Tumor

Stichwörter der Autor:innen

ADIPOQGAS5GATA4TNBCYAP1

Substanzen

YAP1 protein, humanYAP-Signaling ProteinsAdiponectinGATA4 protein, humanAdaptor Proteins, Signal TransducingGATA4 Transcription FactorTranscription FactorsADIPOQ protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Surgical Oncology, Institute of Oncology, Poznan University of Medical Sciences Szamarzewskiego 84, 60-569 Poznan, Poland.
  • Department of Oncological Physiotherapy, Medical University of Lodz, Paderewskiego 4, 93-509 Lodz, Poland.
  • Department of General, Gastroenterological and Oncological Surgery, Warsaw Medical University, Banacha 1a, 02-097 Warsaw, Poland.
  • Department of Translational Research, Nofer Institute of Occupational Medicine, St. Teresy 8 Street, 91-348 Lodz, Poland.
  • Department of Chemical Safety, Nofer Institute of Occupational Medicine, St. Teresy 8 Street, 91-348 Lodz, Poland.
  • Department of Biostatistics and Translational Medicine, Medical University of Lodz, Mazowiecka 15, 92-215 Lodz, Poland.

ORCID-Profile: Katarzyna Skrzypek, Ewa Jabłońska, Katarzyna Płoszka, Damian Kołat, Sylwia Paszek, Izabela Zawlik, Elżbieta Płuciennik, Natalia Potocka, Paulina Gibowska-Maruniak

Zitieren

APA

Wichtowski, M., Kołacińska-Wow, A., Skrzypek, K., Jabłońska, E., Płoszka, K., Kołat, D., Paszek, S., Zawlik, I., Płuciennik, E., Potocka, N., Fendler, W., Kurzawa, P., Bigos, P., Urbański, Ł., Gibowska-Maruniak, P., & Wow, T. (2025). Molecular Implications of ADIPOQ, GAS5, GATA4, and YAP1 Methylation in Triple-Negative Breast Cancer Prognosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110652

Vancouver

Wichtowski M, Kołacińska-Wow A, Skrzypek K, Jabłońska E, Płoszka K, Kołat D, et al. Molecular Implications of ADIPOQ, GAS5, GATA4, and YAP1 Methylation in Triple-Negative Breast Cancer Prognosis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110652

BibTeX
@article{Wichtowski2025,
  author = {Wichtowski, Mateusz and Kołacińska-Wow, Agnieszka and Skrzypek, Katarzyna and Jabłońska, Ewa and Płoszka, Katarzyna and Kołat, Damian and Paszek, Sylwia and Zawlik, Izabela and Płuciennik, Elżbieta and Potocka, Natalia and Fendler, Wojciech and Kurzawa, Paweł and Bigos, Paweł and Urbański, Łukasz and Gibowska-Maruniak, Paulina and Wow, Thomas},
  title = {Molecular Implications of ADIPOQ, GAS5, GATA4, and YAP1 Methylation in Triple-Negative Breast Cancer Prognosis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110652}
}
Kostenlos starten →